InnovAge Holding Corp.

INNV Nasdaq SEC CIK 1834376
Follow InnovAge Holding Corp. Weekly email: filings, results

Financials

Reported figures only · latest: Q1 2027 USD · US GAAP
Revenue, last quarter $264.8M +12.1% vs same quarter last year
Net income $19.6M +143.8% vs same quarter last year
EPS, diluted $0.14 +133.3% vs same quarter last year
Operating cash flow $28.7M +632.5% vs same quarter last year
Revenue by quarter
$209M
$218.1M
$221.4M
$236.1M
$239.7M
$251.9M
$262M
$264.8M
Q2 25 Q3 25 Q4 25 Q1 26 Q2 26 Q3 26 Q4 26 Q1 27

Source: SEC XBRL filings · latest filing

The long view

Fiscal years as reported · SEC XBRL filings, US GAAP
Revenue and net income8 fiscal years
  • Revenue
  • Net income
−$500M$0$500M$1BFY19FY20FY21FY22FY23FY24FY25FY26
Show the numbers
YearRevenueNet income
FY26$989.7M−$2.5M
FY25$853.7M−$30.3M
FY24$763.9M−$21.3M
FY23$688.1M−$40.7M
FY22$698.6M−$6.5M
FY21$637.8M−$44M
FY20$567.2M$26.3M
FY19--
MarginsShare of revenue
  • Gross margin
  • Operating margin
  • Net margin
−10%0%10%20%30%FY19FY20FY21FY22FY23FY24FY25FY26
Show the numbers
YearGross marginOperating marginNet margin
FY2623%0.3%−0.3%
FY2518%−3.5%−3.6%
FY2417.3%−3%−2.8%
FY2314.7%−7.2%−5.9%
FY2219.4%−0.6%−0.9%
FY21-−1.9%−6.9%
FY20-9%4.6%
FY19---
Free cash flowOperating cash flow minus capital expenditure
−$50M−$25M$0$25M$50M$75MFY19FY20FY21FY22FY23FY24FY25FY26
Show the numbers
YearFree cash flow
FY26$50.4M
FY25$26.6M
FY24−$44.8M
FY23−$3.1M
FY22−$10.9M
FY21−$25.1M
FY20$32M
FY19-
Net margin vs the sectorMedian of Healthcare companies filing with the SEC
  • InnovAge Holding Corp.
  • Healthcare median
−100%−75%−50%−25%0%25%FY19FY20FY21FY22FY23FY24FY25FY26
Show the numbers
YearInnovAge Holding Corp.Healthcare median
FY26−0.3%−11.1%
FY25−3.6%−30.6%
FY24−2.8%−47%
FY23−5.9%−58%
FY22−0.9%−80.4%
FY21−6.9%−71.8%
FY204.6%−62.2%
FY19-−46.2%